PromptBase
🤖 GPT
✨ Introducing the ultimate tool for anyone who needs to create multiple choice questions!
🧠 This prompt makes chatGPT read any text and extract the most relevant information to create questions that are accurate and effective
With just a few clicks, you'll have a customized study or teaching aid that will help you excel in your studies or engage your students in learning
✅ Works with any text
✅ Choose between 3 difficulties: easy, medium and hard
✅ Choose the best question among countless
...more
$3.99
After purchasing, you will gain access to the prompt file which you can use with GPT or the app builder. You'll receive 20 free generation credits with this purchase. By purchasing this prompt, you agree to our terms of service.
Over 1 month ago
Prompt Details
Model
Chat - GPT-3.5 (gpt-3.5-turbo)
Token size
237 ($0.00050 / call)
Example input
[Difficulty]: Medium
[Text]: "Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research. Abstract
Heterogeneity in the clinical presentation of SARS-CoV-2 infection and COVID-19 progression underscores the urgent need to identify individual-level susceptibility factors that affect infection vulnerability and disease severity. Tobacco product use is a potential susceptibility factor. In this Personal View, we provide an overview of the findings of peer-reviewed, published studies relating tobacco product use to SARS-CoV-2 infection and COVID-19 outcomes, with most studies focusing on cigarette smoking in adults. Findings pertaining to the effects of tobacco product use on the incidence of SARS-CoV-2 infection are inconsistent. However, evidence supports a role for cigarette smoking in increasing the risk of poor COVID-19 outcomes, including hospital admission, progression in disease severity, and COVID-19-related mortality. We discuss the potential effects of tobacco use behaviour on SARS-CoV-2 transmission and infection, and highlight the pathophysiological changes associated with cigarette smoking that could promote SARS-CoV-2 infection and increased disease severity. We consider the biological mechanisms by which nicotine and other tobacco product constituents might affect immune and inflammatory responses to SARS-CoV-2 infection. Finally, we identify current knowledge gaps and suggest priorities for research to address acute and post-acute health outcomes of COVID-19 during and after the pandemic."
Example output
Sure, I can create a quiz based on the text you have provided. Here are five questions of medium difficulty level:
Which of the following is a potential susceptibility factor for SARS-CoV-2 infection and COVID-19 outcomes?
A) Drinking coffee
B) Regular exercise
C) Tobacco product use
D) Adequate sleep
What do the findings of peer-reviewed studies suggest about the relationship between cigarette smoking and SARS-CoV-2 infection?
A) Cigarette smoking increases the risk of SARS-CoV-2 infection
B) Cigarette smoking decreases the risk of SARS-CoV-2 infection
C) Cigarette smoking has no effect on the risk of SARS-CoV-2 infection
D) The findings are inconsistent
Which of the following is NOT a poor COVID-19 outcome associated with cigarette smoking?
A) Hospital admission
B) Progression in disease severity
C) COVID-19-related mortality
D) Mild COVID-19 symptoms
What do the authors of the text suggest about the potential effects of tobacco use behaviour on SARS-CoV-2 transmission and infection?
A) Tobacco use behaviour has no effect on SARS-CoV-2 transmission and infection
B) Tobacco use behaviour can decrease the risk of SARS-CoV-2 transmission and infection
C) Tobacco use behaviour can increase the risk of SARS-CoV-2 transmission and infection
D) The authors do not discuss the potential effects of tobacco use behaviour on SARS-CoV-2 transmission and infection
What is the final recommendation of the authors of the text regarding research priorities for COVID-19?
A) To identify individual-level susceptibility factors for COVID-19
B) To focus on acute health outcomes of COVID-19 during the pandemic
C) To focus on post-acute health outcomes of COVID-19 after the pandemic
D) To address both acute and post-acute health outcomes of COVID-19 during and after the pandemic